NEW — Intraday Technical Analysis now available from TRADING Central.
Visit News, Commentary & Events.

Snapshot: XLV


72.84up0.26 (0.36%)

 as of 4:00:00pm ET 03/05/2015
Bid/Size 60.00/0
Ask/Size 0.00/0
Open 72.67
High 73.17
Low 72.58
Previous Close
AS OF 03/05/2015
Price Performance (Last 52 Wk)
as of 03/04/2015
Volume 0
Volume (90-Day Average) 9,726,390
Indicative Intraday Value Log in
NAV (Previous Day)
AS OF 03/05/2015
Bid/Ask Midpoint (Previous Day)
AS OF 03/05/2015
Bid/Ask Spread (1 Month Average)
as of 01/30/2015
Premium / Discount (Bid/Ask Previous Day)
as of 03/05/2015
Premium / Discount (1 Month Rolling Average)
as of 03/04/2015
Tracking Error 0.06
Options Yes
Detailed Quote

Note: You can save only one view at the time. Saving this view will overwrite your previously saved view.

Please use the Advanced Chart if you want to have more than one view.

Save View
Your view has been saved
Your view hasn't been saved
TODAY 2D 5D 10D 1M 3M 6M YTD 1Y 3Y 5Y 10Y
Text Note
Chart Settings

Please note you can display only one indicator at a time in this view. Please use Advanced Chart if you want to display more than one.


Please note you can display only one indicator at a time in this view. Please use Advanced Chart if you want to display more than one.

Don't show again

ETP Type


Asset Class


Geography Objective


Capitalization / Style Objective

Large Cap / Core or Blend

Sector Objective


Net Assets
AS OF 02/28/2015


Net Expense Ratio



SSGA Funds Management, Inc / SPDRs

Inception Date


Investment Philosophy

Passively Managed

Benchmark Index

S&P Health Care Select Sector Index

Index Composition


Legal Structure

Open-End Investment Company

Basket Total Holdings



The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Learn More

News, Commentary & Events

Log in for more news
  • Show article details.

    SPDR® ETF Family Announces Impact of Receiving Settlement Payment

    Business Wire - 02/10/2015
    The SPDR® Exchange Traded Funds listed in the table below, announced today that each fund received a payment as an authorized claimant from a class action settlement related to Merck & Co., Inc. The total payment to be received by each Fund is listed below. State Street manages more than $466.4 billion in SPDR ETF assets worldwide, and is one of the largest ETF providers in the US and globally.
  • Show article details.

    Health-care sector taking a broad beating as pricing fears grow

    MarketWatch - 12/23/2014
    The health-care sector was taking a broad beating in afternoon trade Tuesday, as concerns over drug pricing grew. The SPDR Health Care Select Sector ETF, or "XLV," was down 2.3%. Among the XLV's most heavily-weighted members, the shares of Johnson& Johnson dropped 2.5%, of Pfizer fell 2.4% and of Merck& Co.' s slid 2.9%.
  • Sector Detector: Energy sector rains on bulls' parade, but skies may clear soon

    BY Scott Martindale, Sabrient - 12/14/2014

    Stocks have needed a reason to take a breather and pull back in this long-standing ultra-bullish climate, with strong economic data and seasonality providing impressive tailwinds -- and plummeting oil prices certainly have given it to them. But this minor pullback was fully expected and indeed desirable for market health. The future remains bright for the U.S. economy and corporate profits despite the collapse in oil, and now the overbought technical condition has been relieved. While most sectors are gathering fundamental support and our sector rotation model remains bullish, the Energy sector looks fundamentally weak and continues to rank at the bottom of our forward-looking sector rankings. The charts suggest that this is the minor (but still significant) pullback that I projected, and I am hopeful that it is sufficient to avoid a more dramatic event in early January. Overall, this week's fundamentals-based Outlook rankings still look bullish to me. Downward earnings revisions from Wall Street have subsided (with the exception of Energy) and in fact some sectors are getting increasingly positive revisions. The top four sectors are all economically-sensitive (or in the case of Healthcare, all-weather), and they also display some of the highest Bull scores. Our sector rotation model continues to show a bullish bias and suggests holding Healthcare, Industrial, and (surprise!) Basic Materials. Also discussed are some alternative highly-ranked ETFs and individual stock ideas from within the top-ranked sectors, and what the model suggests if you have a neutral or defensive outlook.

  • Equity ETFs Hit New Highs In China Rate Cut

    BY Cinthia Murphy, - 11/21/2014

    Stock index and sector funds having a banner day.Both the S'P 500 and the Dow Jones industrial average rallied to record highs Friday following a surprising interest rate cut in China that all ...

Analyst Opinions

Analyst Ratings

Firm Name As of Date Action Rating Report
S&P Capital IQ 02/28/2014 Upgrade Log in for rating & report
Ned Davis Research Group 10/16/2014 Upgrade Log in for rating & report
Sabrient Systems 02/24/2015 Downgrade Log in for rating & report
XTF Inc. 01/30/2015 Upgrade 9.90000 out of 10 XTF Inc. PDF Report
Morningstar, Inc.** 07/31/2014 Upgrade 3 out of 53 out of 53 out of 53 out of 53 out of 5
Overall - 23 Health funds rated
Morningstar, Inc. PDF Report
More Analyst Opinions

Key Statistics

Price / Earnings (Trailing Twelve Months) 24.79
Price / Book 4.04
Price / Sales 1.95
Price / Cash Flow 16.85
30-day SEC Yield
AS OF 02/27/2015
Distribution Yield (TTM)
AS OF 02/28/2015
See all Key Stats


Asset Class Median
Volume (10-Day Avg)
AS OF 03/04/2015
7.7M 23.3M
1 Week Market Total Return
AS OF 03/03/2015
-0.26% -0.31%
1 Month Market Total Return
AS OF 03/03/2015
+2.99% +2.47%
1 Year Market Total Return
AS OF 03/03/2015
+24.21% +7.58%
3 Year Annualized Market Total Return
AS OF 03/03/2015
+27.98% +11.93%
Beta (1 Year Month-End)
AS OF 02/28/2015
0.63 1.03
Annual Turnover Ratio
AS OF 09/30/2014
2.99% 17.72%
Net Expense Ratio
AS OF 01/31/2015
0.15% 0.58%
Compare to Other ETFs


Growth of Hypothetical $10,000 * AS OF 02/28/2015

Cumulative Total Returns AS OF 03/03/2015
NAV Return Market Return S&P 500 Index
YTD +5.63% +5.63% +2.31%
4 Weeks +3.02% +2.99% +3.04%
13 Weeks +3.12% +3.10% +1.80%
26 Weeks +13.48% +13.47% +6.13%
Quarter-End Average Annual Total Returns AS OF 12/31/2014
NAV Return Market Return
1 Year +25.17% +25.14%
3 Year +27.62% +27.59%
5 Year +19.18% +19.25%
10 Year +10.44% +10.43%
Life +8.21% +8.20%
Life as of inception date: 12/16/1998       Gross Expense Ratio: 0.15%

The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.

More about Performance & Risk

Portfolio Composition

Top 10 Basket Holdings AS OF 03/04/2015

View all Basket Holdings
JNJ Johnson & Johnson 10.22%
PFE Pfizer Inc 7.84%
MRK Merck & Co Inc 5.92%
GILD Gilead Sciences Inc 5.58%
AMGN Amgen Inc 4.35%
MDT Medtronic PLC 4.00%
UNH UnitedHealth Group Inc 3.95%
BMY Bristol-Myers Squibb Co 3.93%
BIIB Biogen Idec Inc 3.59%
ABBV AbbVie Inc 3.45%
†Part or all of this cash position may represent cash-in-lieu of marketable securities and not actual cash.Click here for more information.More about Portfolio Composition


as of 03/04/2015 More information
Value Blend Growth
Large StyleMap: Large Growth
Current HistoricalCurrent Fund Assets Coverage: 100%
Data provided by . More about Portfolio Composition
Free commission offer applies to online purchases of Fidelity ETFs and select iShares ETFs in a Fidelity brokerage account. Fidelity accounts may require minimum balances. The sale of ETFs is subject to an activity assessment fee (of between $0.01 to $0.03 per $1,000 of principal). iShares ETFs and Fidelity ETFs are subject to a short-term trading fee by Fidelity if held less than 30 days. *The chart illustrates the NAV performance of a hypothetical $10,000 investment made in the fund on 12/31/1999 or on commencement of operations (whichever is later). Figures include reinvestment of capital gains and dividends, but do not reflect the effect of any applicable sales charges or redemption fees, which would lower these figures. This chart is not intended to imply any future performance of the fund.

**The Overall Morningstar RatingTM for a fund is derived from a weighted average of the performance figures associated with its three-, five-, and ten-year (if applicable) Morningstar Rating metrics. For each fund with at least a three-year history, Morningstar calculates a Morningstar Rating based on a Morningstar Risk-Adjusted Return measure that accounts for variation in a funds monthly performance (including the effects of sales charges, loads and redemption fees), placing more emphasis on downward variations and rewarding consistent performance. The top 10% of funds in each category receive 5 stars, the next 22.5% receive 4 stars, the next 35% receive 3 stars, the next 22.5% receive 2 stars and the bottom 10% receive 1 star. (Each share class is counted as a fraction of one fund within this scale and rated separately, which may cause slight variations in the distribution percentages.)

The performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. Click on the "Performance & Risk" link to view quarter-end performance. Average annual total returns are historical and include change in share value and reinvestment of dividends and capital gains, if any. Cumulative total returns are reported as of the period indicated. Life of fund figures are reported as of the commencement date to the period indicated. Since ETFs are bought and sold at prices set by the market - which can result in a premium or discount to NAV- the returns calculated using market price (market return) can differ from those calculated using NAV (NAV return).

Top basket holdings are as of the date indicated and may not be representative of the funds current or future investments.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive, long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Additional information about the sources, amounts, and terms of compensation is described in the ETFs prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.